Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.1 USD | +17.49% | +36.60% | +43.96% |
05-13 | Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-17 | North American Morning Briefing : Stock Futures -2- | DJ |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
13.55M | - | - | - | - | - | |
63.85B | - | |||||
41.83B | ||||||
40.65B | ||||||
27.12B | ||||||
26.52B |